Mario Philips
Director/Board Member bei ORGENESIS INC.
Vermögen: - $ am 31.03.2024
Profil
Mario Philips is currently the Chairman & Chief Executive Officer at Polyplus-transfection SA since 2023.
He is also the Chief Executive Officer at Polyneuros SAS since 2019 and an Independent Director at Orgenesis, Inc. since 2020.
In his former positions, Mr. Philips served as the Chairman at Clean Biologics.
He was a Director at Artelis SA (Belgium) from 2007 to 2011 and at Eurofins Disposable Lab SASU from 2009 to 2019.
He also held the position of Director at Austar Lifesciences Ltd.
from 2007 to 2019.
Additionally, he was a Senior Vice President at ATMI, Inc. from 2012 to 2013 and Vice President & General Manager at Danaher Corp.
from 2014 to 2019.
Mr. Philips was also the General Manager at ATMI LifeSciences from 2010 to 2014.
Mr. Philips completed his undergraduate degree at Ghent University and his graduate degree at Groep T.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ORGENESIS INC.
-.--% | 20.12.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Mario Philips
| Unternehmen | Position | Beginn |
|---|---|---|
| ORGENESIS INC. | Director/Board Member | 09.01.2020 |
| Polyneuros SAS | Chief Executive Officer | 01.03.2019 |
Polyplus-transfection SA
 Polyplus-transfection SA BiotechnologyHealth Technology Polyplus-transfection SA develops and sells solutions for the delivery of nucleic acids in research, bio production, and therapeutics. Its products are transfection reagents and trademarks, mainly for gene and cell therapies. The company was founded by Jean-Paul Behr, Anne-Lise Monjanel, Joelle Bloch, and Patrick Metz in January 2001 and is headquartered in Illkirch-Graffenstaden, France. | Chief Executive Officer | 01.11.2020 |
| Pll Therapeutics | Chairman | - |
Ehemalige bekannte Positionen von Mario Philips
| Unternehmen | Position | Ende |
|---|---|---|
| DANAHER CORPORATION | Corporate Officer/Principal | 01.03.2019 |
| AUSTAR LIFESCIENCES LIMITED | Director/Board Member | 01.03.2019 |
Eurofins Disposable Lab SASU
 Eurofins Disposable Lab SASU Medical DistributorsDistribution Services Eurofins Disposable Lab SASU provides technology solutions for aseptic formulation and manufactures pharmaceutical products. It also process sterile products using its own proprietary disposable technologies. The company was founded on November 19, 2008 and is headquartered in Martillac, France. | Director/Board Member | 01.03.2019 |
ATMI LifeSciences
 ATMI LifeSciences Medical SpecialtiesHealth Technology ATMI LifeSciences was provided bioprocessing and fluid-handling solutions to the biopharmaceutical, vaccine and cellular therapy industries. The company was headquartered in Minneapolis, MN. | Corporate Officer/Principal | 01.03.2014 |
Artelis SA (Belgium)
 Artelis SA (Belgium) Environmental ServicesIndustrial Services Artelis is a technology company that provides disposable bio process solutions, from optimization to intensification: ' Process intensification: design, development and manufacturing of innovative high-cell-density technologies that enable to dramatically increase volumetric productivity while significantly reduce the manufacturing scales. ' Process optimization: process development services with a view to improve customer's process Artelis' team comprises 40 individuals all of whom are highly experienced in cell culture and well aware of biotechnology companies' needs. | Director/Board Member | 01.11.2011 |
Ausbildung von Mario Philips
| Ghent University | Undergraduate Degree |
| Groep T | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| DANAHER CORPORATION | Health Technology |
| ORGENESIS INC. | Health Technology |
| AUSTAR LIFESCIENCES LIMITED | Producer Manufacturing |
| Private Unternehmen | 8 |
|---|---|
ATMI, Inc.
 ATMI, Inc. SemiconductorsElectronic Technology ATMI, Inc. provides materials and materials packaging for manufacturing semiconductors and flat panel displays. The company was founded by Eugene G. Banucci, Glenn Tom, Ward Chas Stevens, Duncan W. Brown and W. Karl Olander in 1986 and is headquartered in Danbury, CT. | Electronic Technology |
ATMI LifeSciences
ATMI LifeSciences Medical SpecialtiesHealth Technology ATMI LifeSciences was provided bioprocessing and fluid-handling solutions to the biopharmaceutical, vaccine and cellular therapy industries. The company was headquartered in Minneapolis, MN. | Health Technology |
Artelis SA (Belgium)
Artelis SA (Belgium) Environmental ServicesIndustrial Services Artelis is a technology company that provides disposable bio process solutions, from optimization to intensification: ' Process intensification: design, development and manufacturing of innovative high-cell-density technologies that enable to dramatically increase volumetric productivity while significantly reduce the manufacturing scales. ' Process optimization: process development services with a view to improve customer's process Artelis' team comprises 40 individuals all of whom are highly experienced in cell culture and well aware of biotechnology companies' needs. | Industrial Services |
Eurofins Disposable Lab SASU
Eurofins Disposable Lab SASU Medical DistributorsDistribution Services Eurofins Disposable Lab SASU provides technology solutions for aseptic formulation and manufactures pharmaceutical products. It also process sterile products using its own proprietary disposable technologies. The company was founded on November 19, 2008 and is headquartered in Martillac, France. | Distribution Services |
| Polyneuros SAS | |
| Clean Biologics | |
| Pll Therapeutics | |
Polyplus-transfection SA
Polyplus-transfection SA BiotechnologyHealth Technology Polyplus-transfection SA develops and sells solutions for the delivery of nucleic acids in research, bio production, and therapeutics. Its products are transfection reagents and trademarks, mainly for gene and cell therapies. The company was founded by Jean-Paul Behr, Anne-Lise Monjanel, Joelle Bloch, and Patrick Metz in January 2001 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
